Brown University and Rhode Island’s Lifespan Hospital launched COVID-19 biobank

In an effort to better understand how to diagnose and treat patients with COVID-19, physician-scholars at the Brown-based Advance Clinical and Translational Research (Advance-CTR) have partnered with Rhode Island’s Lifespan health system to create a bank of plasma and serum samples from patients who have been tested for novel coronavirus.

The biobank is helping more than a dozen teams of Brown researchers confront questions that every medical professional working amid the pandemic wants to be answered, including –

  1. How best to diagnose positive cases of COVID-19,
  2. How to predict the immune responses of individuals with the virus, and
  3. How to prevent hospitalized patients from suffering long-term damage to their health

Click here to read more.

    By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

    The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
    Feel free to Contact Us for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


      Avoid Gmail, Yahoo, etc. please.

      By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        The Features PDF has been emailed to you.
        Feel free to "Schedule a Demo" or "Contact Us" for any questions.

        Srikanth Adiga,
        C.E.0, OpenSpecimen
        Email: sri@krishagni.com

          By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.